1. Tomographic findings in patients with COVID-19 according to evolution of the disease
- Author
-
Oswaldo Quispe-Chirinos, Yoselyn Anticona-De-La-Cruz, Axel Quispe-Cholan, Edward Chavez-Cruzado, Marco Cornejo-Cruz, and Veronica Moreno-Lazaro
- Subjects
X-ray computed tomography ,lcsh:Medical physics. Medical radiology. Nuclear medicine ,Disease progression ,medicine.medical_specialty ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,business.industry ,lcsh:R895-920 ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Chest ct ,Review ,Coronavirus infections ,English language ,Disease ,Lung involvement ,Diagnosis ,medicine ,Radiology, Nuclear Medicine and imaging ,In patient ,Radiology ,business - Abstract
Background The tomographic findings in COVID-19, its classification, a brief overview of the application of artificial intelligence, and the stages during the course of the disease in patients with moderate COVID-19 Main body Chest CT allows us to follow the course of COVID-19 in an objective way; each phase has characteristic imaging findings and, consequently, takes the corresponding measures. A search was made in the PubMed database with the keywords extracted from the DeCs and the combinations of these. Only articles published between December 2019 and June 2020 were included. The search was limited to the English language. Conclusions CT serves to monitor the course of the disease since it assesses the severity of lung involvement. The most frequent finding is bilateral ground glass opacities with a subpleural distribution. The progression occurs in two phases: one slow and one fast. At discharge, the patient may have ground glass opacities or areas that will later become fibrosis, leaving sequelae for life.
- Published
- 2020
- Full Text
- View/download PDF